Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China
· Delayed Price · Currency is CNY 31.77
-0.12 (-0.38%)
At close: Apr 25, 2025, 2:57 PM CST
SHA:688139 Revenue
In the year 2024, Qingdao Haier Biomedical Co.,Ltd had annual revenue of 2.28B CNY with 0.13% growth. Qingdao Haier Biomedical Co.,Ltd had revenue of 501.81M in the quarter ending December 31, 2024, with 10.40% growth.
Revenue
2.28B
Revenue Growth
+0.13%
P/S Ratio
4.40
Revenue / Employee
813.62K
Employees
2,807
Market Cap
10.04B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |